羥氯喹已測過N次 － 各國試驗結果都一樣：無效。
－ 歐盟多國禁止使用羥氯喹治療新冠患者 英國叫停牛津大學試驗 (試驗了175個醫院，11,000人), 試驗的結論是根本沒用。
（http://news.cctv.com/2020/05/28/ARTIJsihnQybk9wkdud47BbD200528.shtml ）
－上海市公共衛生臨床中心對30例羥氯喹的回顧性分析[2]，發現標準劑量的硫酸羥氯喹（400 mg，1次/d）治療並未顯示出具有改善患者症狀、加速病毒學抑製等方麵的臨床效果。
（https://zhuanlan.zhihu.com/p/112308041）
－New England Journal of Medicine’s study over 1561 patients (who received HCQ) and 3155 patients (who received usual care) shows: patients who received HCQ did not have a lower incidence of death.
( https://www.nejm.org/doi/full/10.1056/NEJMoa2022926 )
伊維菌素也一樣：
美國醫學會和美國藥劑師協會都呼籲了：不要再用這種藥治新冠了。
The American Medical Association and American Pharmacist Association have both come out and urged people to not take Ivermectin to treat Covid. (See: https://pharmacist.com/APhA-Press-Releases/ama-apha-ashp-call-for-immediate-end-to-prescribing-dispensing-and-use-of-ivermectin-to-prevent-or-treat-covid-19-outside-clinical-trials )
FDA 還有中文網站，告訴大家為啥不要用這藥治新冠。
（https://www.fda.gov/consumers/consumer-updates/weishenmebuyinggaishiyongyiweijunsuzhiliaohuoyufang2019xinguanfeiyan
伊維菌素的製造廠商Merck 都說了：他們這藥對新冠沒用（＂No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies＂）。
(https://www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/)
